Cover image of the article: Virotherapy in Cancer

Image Credit:Int J Cancer Manag

Virotherapy in Cancer

Authors

Gholamreza Motalleb1,*
1Dept. of Biology, Faculty of Science, University of Zabol, Iran
*Corresponding Author: Corresponding author: Gholamreza Motalleb, Dept. of Biology, Faculty of Science, University of Zabol, Iran, Tel: +98-5422242503, E-mail: Email: reza.motaleb@uoz.ac.ir

International Journal of Cancer Management:Vol. 6, issue 2; e80409
Published online:Jun 30, 2013
Article type:Review Article
Received:Jan 17, 2013
Accepted:Apr 08, 2013
How to Cite:Motalleb G. Virotherapy in Cancer. Int J Cancer Manag. 2013;6(2):e80409. doi:

Abstract

New cancer therapies with novel mechanisms and functions are needed to treat patients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its self-perpetuating nature provides an ideal platform for therapeutic transgenic insertion. In this review article, a variety of oncolytic viruses in cancer gene therapy will be described.

Highlights

Fulltext

The Full text is available in PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

2
Jun
2022
Cancer virotherapy: Targeting cancer cells by microRNA mechanism for selective replication of oncolytic viruses in these cells

Cancer virotherapy: Targeting cancer cells by microRNA mechanism for selective replication of oncolytic viruses in these cells

Ehsan Kakavandi,
maryam beiranvand,
Sharareh Moghim

Kakavandi E, beiranvand M, Moghim S. Cancer virotherapy: Targeting cancer cells by microRNA mechanism for selective replication of oncolytic viruses in these cells. koomesh. 2022;24(3):e152737. doi:

19
Sep
2022
Isolation and Characterization of a Discrete Genetically Homogeneous Viral Subpopulation of Mumps Virus RS-12 Strain with Superior Oncolytic Potency Compared to Its Progenitor Virus

Isolation and Characterization of a Discrete Genetically Homogeneous Viral Subpopulation of Mumps Virus RS-12 Strain with Superior Oncolytic Potency Compared to Its Progenitor Virus

Behnam Alirezaie,
Abolhasan Foroughi,
Ashraf Mohammadi

Alirezaie B, Foroughi A, Mohammadi A. Isolation and Characterization of a Discrete Genetically Homogeneous Viral Subpopulation of Mumps Virus RS-12 Strain with Superior Oncolytic Potency Compared to Its Progenitor Virus. Int J Cancer Manag. 2022;15(9):e122781. doi: https://doi.org/10.5812/ijcm-122781

27
May
2013
Viral Evasion and Subversion Mechanisms of the Host Immune System

Viral Evasion and Subversion Mechanisms of the Host Immune System

Mehran Ghaemi-Bafghi,
alireza Haghparast

Ghaemi-Bafghi M, Haghparast A. Viral Evasion and Subversion Mechanisms of the Host Immune System. Zahedan J Res Med Sci. 2013;15(10):e92814. doi:

28
Sep
2020
Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines

Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines

Behnam Alirezaie,
Ashraf Mohammadi,
Arash Ghalyanchi Langeroudi,
Roozbeh Fallahi,
Ali Reza Khosravi

Alirezaie B, Mohammadi A, Ghalyanchi Langeroudi A, Fallahi R, Khosravi AR. Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines. Int J Cancer Manag. 2020;13(9):e103111. doi: https://doi.org/10.5812/ijcm.103111

14
Aug
2012
Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes

Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes

Seyed Younes Hosseini,
Farzaneh Sabahi,
Seyed Mohammad Moazzeni,
Mohammad Hossein Modarressi,
Mehdi Saberi Firoozi,
Mehrdad Ravanshad

Hosseini S, Sabahi F, Moazzeni S, Modarressi M, Saberi Firoozi M, et al. Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes. Hepat Mon. 2012;12(8):6130. doi: https://doi.org/10.5812/hepatmon.6130

More by these authors

Gholamreza MotallebPubMedScholar
Share
Cited by
Metrics